Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
diCELLa is a software and services provider for clinical trials and medical research, with a core focus on Electronic Data Capture, namely eCRF/EDC. According to its website, the team is based in Poland, uses a +48 phone country code, and claims to have established clinical collaboration in the United States. Its products cover not only clinical research, but also vertical medical applications such as medical image analysis, cell counting, biobanks, and transplant workflows.
In terms of functionality, diCELLa’s main offering is eCRF/EDC, typically combined with CTMS to strengthen clinical trial oversight. It also provides eISF/eTMF document management, IWRS for patient enrollment/randomization/drug supply management, and data or imaging repositories. On the services side, it offers protocol preparation, CRF development, conversion of paper CRFs to eCRFs, data entry and validation, data cleaning, statistical analysis, remote training, and Help Desk support. For collaboration, the website explicitly mentions role-based permissions and access control for sponsors, researchers, monitors, and other roles, making it suitable for multi-role, multi-center trial management.
Pricing is quote-based, with no public plans available. Quotes are customized based on factors such as license duration, number of sites, number of patients, number of users, study phase, languages, IWRS/eTMF/eISF requirements, data warehouse, training, support, data export, and archiving. As such, it is closer to project-based enterprise software procurement. Compliance is one of its key selling points: the website discloses ISO 9001:2015 and ISO 27001:2013 certifications, and mentions alignment with FDA, 21 CFR Part 11, HIPAA, ICH GCP, GAMP5 CSV, EU GMP Annex 11, and other requirements. It also claims to use patented blockchain-based data protection technology.
The main advantage is that its clinical trial modules are relatively comprehensive, covering not only EDC but also CTMS, eTMF/eISF, IWRS, and data management services. It supports rapid customization based on study protocols, and the website claims it can provide a demo or initial system version relatively quickly. It also presents a fairly clear medical compliance narrative. The downsides are that the website does not publish pricing, plans, API documentation, developer support, or a list of third-party integrations. On deployment, it only states that the system is web-based, uses an internet database, and may include server/web hosting; whether private or on-premises deployment is supported is unclear.
diCELLa is better suited to biopharma companies, medical device companies, CROs, digital therapeutics companies, and academic research institutions, especially clinical projects where the vendor is expected to participate in CRF design, data cleaning, statistical analysis, and training. Its accessibility from China cannot be determined from the website text. Network connectivity, cross-border data compliance, RMB payment, and local contract support should all be confirmed before procurement. If a Chinese-language ecosystem or local deployment is required, domestic clinical EDC/CTMS vendors may be worth comparing; international alternatives include Medidata Rave, Veeva Vault EDC, Oracle Clinical One, Castor EDC, REDCap, and OpenClinica.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on dicella.com official site.
dicella.com is an Poland Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach dicella.com directly.